New tentative approval for Teva Pharms drug dasatinib

Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in three NDAs. There are two patents protecting this compound. Drug…
The post New tentative approval for Teva Pharms drug dasatinib app…


New patent for Kaleo Inc drug AUVI-Q

Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are thirty-one patents…
The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatentW…


Biotechblog